Induction Chemotherapy for Advanced Nasopharyngeal Carcinoma - Is This the New Standard of Care?

Maurice Willis

doi:10.1001/jamaoncol.2022.0082

Induction Chemotherapy for Advanced Nasopharyngeal Carcinoma - Is This the New Standard of Care?

Maurice Willis

Internal Medicine

Research output: Contribution to journal › Comment/debate › peer-review

2 Scopus citations

Original language	English (US)
Pages (from-to)	715-716
Number of pages	2
Journal	JAMA oncology
Volume	8
Issue number	5
DOIs	https://doi.org/10.1001/jamaoncol.2022.0082
State	Published - May 2022

ASJC Scopus subject areas

Oncology
Cancer Research

Access to Document

10.1001/jamaoncol.2022.0082

Cite this

@article{49cee82bc08b49e089b80731c4e3a7a1,

title = "Induction Chemotherapy for Advanced Nasopharyngeal Carcinoma - Is This the New Standard of Care?",

author = "Maurice Willis",

year = "2022",

month = may,

doi = "10.1001/jamaoncol.2022.0082",

language = "English (US)",

volume = "8",

pages = "715--716",

journal = "JAMA oncology",

issn = "2374-2437",